Literature DB >> 12706950

Is treatment-resistant depression a unique subtype of depression?

Andrea Fagiolini1, David J Kupfer.   

Abstract

Treatment-resistant depression (TRD) continues to represent a major challenge for treating clinicians. This report reviews the relevant literature to evaluate whether TRD can be considered a specific subtype of depression based on 1) clinical characteristics and course (behavioral phenotype), 2) neurobiological profile, and 3) context and environment in which TRD develops. Although patients with TRD share a number of clinical, neurobiological, and context and environment characteristics, the lack of available data and the clinical heterogeneity of this condition do not currently permit the classification of TRD as a unique subtype of depression; however, this topic is worthy of further evaluation and research. Performing genetics and neuroimaging studies on patients enrolled in large, prospective and controlled studies may provide enough data for classifying TRD (or at least a part of what is currently described as TRD) as a specific subtype of depression. This in turn may facilitate the identification of more effective treatment strategies. Copyright 2003 Society of Biological Psychiatry

Entities:  

Mesh:

Year:  2003        PMID: 12706950     DOI: 10.1016/s0006-3223(02)01670-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  29 in total

Review 1.  Treatment-resistant depression and mortality after acute coronary syndrome.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

2.  Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework.

Authors:  Phil H Lee; Sarah E Bergen; Roy H Perlis; Patrick F Sullivan; Pamela Sklar; Jordan W Smoller; Shaun M Purcell
Journal:  Hum Hered       Date:  2011-08-17       Impact factor: 0.444

3.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

4.  Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Authors:  Mariska Bot; Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; Douglas L Mann
Journal:  J Psychosom Res       Date:  2011-01-15       Impact factor: 3.006

5.  Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies.

Authors:  Na Cai; Karmel W Choi; Eiko I Fried
Journal:  Hum Mol Genet       Date:  2020-09-30       Impact factor: 6.150

6.  Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.

Authors:  S Anttila; K Huuhka; M Huuhka; R Rontu; M Hurme; E Leinonen; T Lehtimäki
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

8.  TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

Authors:  Yun Li; Bryan W Luikart; Shari Birnbaum; Jian Chen; Chang-Hyuk Kwon; Steven G Kernie; Rhonda Bassel-Duby; Luis F Parada
Journal:  Neuron       Date:  2008-08-14       Impact factor: 17.173

9.  Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.

Authors:  José V Pardo; Sohail A Sheikh; Graeme C Schwindt; Joel T Lee; Michael A Kuskowski; Christa Surerus; Scott M Lewis; Faruk S Abuzzahab; David E Adson; Barry R Rittberg
Journal:  Neuroimage       Date:  2008-05-15       Impact factor: 6.556

10.  A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects.

Authors:  Sara B Fleet-Michaliszyn; Isabella Soreca; Amy D Otto; John M Jakicic; Andrea Fagiolini; David J Kupfer; Bret H Goodpaster
Journal:  J Clin Psychiatry       Date:  2008-10-21       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.